Efficacy Study of Combined Treatment With Uric Acid and rtPA in Acute Ischemic Stroke
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 421 participants.
Also called NCT00860366
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 421 participants
- Sponsor
- Angel Chamorro, MD
- Registry
-
NCT00860366
-
- Other papers using this trial's data
- Relevance of Collaterals for the Success of Neuroprotective Therapies in Acute Ischemic Stroke: Insights from the Randomized URICO-ICTUS Trial
- Safety and efficacy of uric acid in patients with acute stroke (URICO-ICTUS): a randomised, double-blind phase 2b/3 trial
- Uric Acid Therapy Improves Clinical Outcome in Women With Acute Ischemic Stroke
- Uric Acid Therapy Prevents Early Ischemic Stroke Progression: A Tertiary Analysis of the URICO-ICTUS Trial (Efficacy Study of Combined Treatment With Uric Acid and r-tPA in Acute Ischemic Stroke)
- Uric acid therapy improves the outcomes of stroke patients treated with intravenous tissue plasminogen activator and mechanical thrombectomy
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Spain
- Registry status
- Completed
Technical summary
Registry record NCT00860366. Randomized; quadruple masking; primary purpose treatment. Start 2011-06 (registry gives no type); primary completion 2013-08 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy Study of Combined Treatment With Uric Acid and rtPA in Acute Ischemic Stroke
- Acronym
- Urico-Ictus
- Condition
- Acute Ischemic Stroke
- Intervention (Drug)
- Uric Acid
- Intervention (Other)
- Vehicle
- Lead sponsor
- Angel Chamorro, MD
- Collaborator
- Carlos III Health Institute
Record details
- Record id
cardio:ct-nct00860366- Content hash
df2079d9a96d1184ab8cc2fdfc711f306df3e40fdb2da1a78ba34ffc39c5872e